MARKET

IMNN

IMNN

Imunon Inc
NASDAQ
2.940
+0.060
+2.08%
Pre Market: 2.840 -0.1 -3.40% 07:54 04/01 EDT
OPEN
2.900
PREV CLOSE
2.880
HIGH
2.940
LOW
2.698
VOLUME
147
TURNOVER
0
52 WEEK HIGH
47.40
52 WEEK LOW
2.520
MARKET CAP
9.03M
P/E (TTM)
-0.2883
1D
5D
1M
3M
1Y
5Y
1D
Imunon FY25 net loss narrows 22% to $14.5 million; cash climbs to $8.8 million
Reuters · 20h ago
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 20h ago
Imunon targets ~80 OVATION 3 patients in the next 12 months as cash runway extends into H2 2026
Seeking Alpha · 21h ago
Imunon Q4 EPS $(1.30) Misses $(1.13) Estimate
Benzinga · 1d ago
Imunon GAAP EPS of -$6.83
Seeking Alpha · 1d ago
IMUNON REPORTS 2025 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE HIGHLIGHTING SIGNIFICANT PROGRESS WITH PIVOTAL PHASE 3 STUDY
Reuters · 1d ago
Earnings Scheduled For March 31, 2026
Benzinga · 1d ago
Here are the major earnings before the open Tuesday
Seeking Alpha · 1d ago
More
About IMNN
Imunon, Inc. is a clinical-stage biotechnology company. The Company is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases, constituting a differentiating approach from conventional therapies. The Company is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the gene-based delivery of cytokines and other therapeutic proteins in the treatment of solid tumors. The second modality, PlaCCine, is developed for the gene delivery of viral antigens that can elicit a strong immunological response. The Company’s lead clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer that has completed Phase 2 development. IMNN-001 works by instructing the body to produce safe and durable levels of powerful cancer-fighting molecules, such as interleukin-12 and interferon gamma, at the tumor site.

Webull offers Imunon Inc stock information, including NASDAQ: IMNN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMNN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMNN stock methods without spending real money on the virtual paper trading platform.